Canada Pension Plan Investment Board boosted its holdings in shares of Avantor by 9.9% in the 4th quarter. now owns 50,759,035 shares of the company's stock worth $1,716,671,000 after buying an additional 439,147 shares in the last quarter. grew its position in Avantor by 0.9% during the first quarter. MD now owns 86,156,553 shares of the company's stock valued at $2,679,469,000 after purchasing an additional 3,164,276 shares during the last quarter. MD boosted its position in Avantor by 3.8% during the second quarter. Several large investors have recently bought and sold shares of the stock. According to data from MarketBeat, Avantor presently has an average rating of 'Moderate Buy' and an average target price of $33.43. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. Finally, UBS Group dropped their price objective on Avantor to $42.00 in a report on Thursday. Ke圜orp dropped their target price on Avantor from $51.00 to $40.00 and set an 'overweight' rating for the company in a research report on Thursday. Barclays dropped their target price on Avantor from $33.00 to $30.00 and set an 'overweight' rating for the company in a research report on Monday, September 12th. Morgan Stanley dropped their target price on Avantor from $40.00 to $37.00 and set an 'overweight' rating for the company in a research report on Monday, August 1st.

Cowen lowered Avantor from an 'outperform' rating to a 'market perform' rating and decreased their price target for the company from $39.00 to $28.00 in a research note on Wednesday, September 14th. Several other analysts have also commented on AVTR. The stock had previously closed at $22.48. The company traded as low as $22.12 and last traded at $22.14, with a volume of 15106 shares changing hands. ( NYSE:AVTR - Get Rating) hit a new 52-week low on Monday after Stifel Nicolaus lowered their price target on the stock from $35.00 to $28.00.

7 Dividend Aristocrats to Help You Take the Bite Out of the Bear.

10 Recession-Proof Stocks That Will Let You Wait Out the Bear.

7 Stocks with the Pricing Power to Push Through High Inflation.

7 Blue-Chip Dividend Stocks That Won’t be Impacted by Rising Interest Rates.

7 Mid-Cap Stocks That Can be the Perfect Fit at Any Time.

7 Stocks to Buy to Outrun Rising Interest Rates.

7 Sports Betting Stocks to Buy for Their Long-Term Possibilities.7 Water Stocks to Buy as the World Dries Up.7 Solar Stocks Leading the Clean Energy Boom.7 Railroad Stocks to Keep Your Portfolio Chugging Along.

7 Agricultural Stocks to Buy to Keep Your Portfolio Well Fed.

This Small-Cap Healthcare Name Is Outperforming Its Index.

Are Smucker & Hostess Buys As Consumers Focus On Food Purchases?.

Humana Proves Vertically Integrated Healthcare Works.

Declining Profits Challenge the CarMax Value Proposition.

How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?.

This Is A Memorable Time To Buy Into Micron Technology.

EV Battery Maker Freyr Set For Major Global Expansion.

The Trader's Guide to Equities Research.

Sheaff brock newsletters